Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
BMC Med Educ ; 23(1): 659, 2023 Sep 11.
Article in English | MEDLINE | ID: mdl-37697275

ABSTRACT

BACKGROUND: Automated Item Generation (AIG) uses computer software to create multiple items from a single question model. There is currently a lack of data looking at whether item variants to a single question result in differences in student performance or human-derived standard setting. The purpose of this study was to use 50 Multiple Choice Questions (MCQs) as models to create four distinct tests which would be standard set and given to final year UK medical students, and then to compare the performance and standard setting data for each. METHODS: Pre-existing questions from the UK Medical Schools Council (MSC) Assessment Alliance item bank, created using traditional item writing techniques, were used to generate four 'isomorphic' 50-item MCQ tests using AIG software. Isomorphic questions use the same question template with minor alterations to test the same learning outcome. All UK medical schools were invited to deliver one of the four papers as an online formative assessment for their final year students. Each test was standard set using a modified Angoff method. Thematic analysis was conducted for item variants with high and low levels of variance in facility (for student performance) and average scores (for standard setting). RESULTS: Two thousand two hundred eighteen students from 12 UK medical schools participated, with each school using one of the four papers. The average facility of the four papers ranged from 0.55-0.61, and the cut score ranged from 0.58-0.61. Twenty item models had a facility difference > 0.15 and 10 item models had a difference in standard setting of > 0.1. Variation in parameters that could alter clinical reasoning strategies had the greatest impact on item facility. CONCLUSIONS: Item facility varied to a greater extent than the standard set. This difference may relate to variants causing greater disruption of clinical reasoning strategies in novice learners compared to experts, but is confounded by the possibility that the performance differences may be explained at school level and therefore warrants further study.


Subject(s)
Clinical Reasoning , Students, Medical , Humans , Learning , Schools, Medical , Software
2.
Pediatr Surg Int ; 34(3): 297-305, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29167984

ABSTRACT

PURPOSE: The embryology of common congenital malformations is discussed controversially. Studies are hampered by a shortage of study material and techniques which require partial or complete preparation and therewith destruction of embryos. X-ray micro-computed-tomography (µCT) is a technical opportunity keeping the embryos intact. Thus, the aim of this study was to assess the applicability of µCT in embryonic research compared to the anatomical information obtained by scanning electron microscopy (SEM). METHODS: Chicken, rat, mouse and sheep embryos, processed either for SEM studies or as whole embryos, were imaged in three-dimensional (3D) using µCT. The obtained two-dimensional (2D) digital datasets were volume rendered by tomographic reconstruction software and studied using analysis software. RESULTS: All embryos were µCT scanned without technical problems. The quality of the µCT images (image contrast, anatomical details) was excellent, but varied depending on age and species studied. µCT imaging allowed a more comprehensive anatomical/morphological analysis but showed less surface details compared to SEM. CONCLUSION: µCT is a technique suitable and innovative for pediatric surgical research, which allows detailed evaluation of entire embryos without time- and specimen-consuming micro-dissection. Samples prepared for SEM can be used for µCT and vice versa.


Subject(s)
Embryo, Mammalian/diagnostic imaging , Imaging, Three-Dimensional , Tomography, X-Ray Computed , Animals , Chick Embryo , Mice , Microscopy, Electron, Scanning , Rats , Sheep
3.
Am J Transplant ; 15(12): 3067-80, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26211786

ABSTRACT

Renal transplantation is the optimum treatment for end-stage renal failure. B cells have been identified in chronic allograft damage (CAD) and associated with the development of tertiary lymphoid tissue within the human renal allograft. We performed renal transplantation in mice to model CAD and identified B cells forming tertiary lymphoid tissue with germinal centers. Intra-allograft B220(+) B cells comprised of IgM(high) CD23(-) B cells, IgM(lo) CD23(+) B cells, and IgM(lo) CD23(-) B cells with elevated expression of CD86. Depletion of B cells with anti-CD20 was associated with an improvement in CAD but only when administered after transplantation and not before. Isolated intra-allograft B cells were cultured and shown to synthesize multiple cytokines, the most abundant of these were GRO-α (CXCL1), RANTES (CCL5), IL-6 and MCP-1 (CCL2). Tubular loss was observed with T cell accumulation within the allograft and development of interstitial fibrosis, whilst type III collagen deposition was observed in areas of F4/80(+) macrophages and PDGFR-ß(+) and transgelin(+) fibroblasts, all of which were reduced by B cell depletion. We have shown that intra-allograft B cells are key mediators of CAD. B cells possibly contribute to CAD by intra-allograft secretion of cytokines and chemokines.


Subject(s)
B-Lymphocytes/pathology , Cytokines/toxicity , Kidney Transplantation , Kidney Tubules/pathology , Nephritis, Interstitial/pathology , Allografts , Animals , Atrophy , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Flow Cytometry , Glomerular Filtration Rate , Graft Rejection/chemically induced , Graft Rejection/immunology , Graft Rejection/metabolism , Graft Rejection/pathology , Graft Survival/drug effects , Humans , Kidney Failure, Chronic/surgery , Kidney Function Tests , Kidney Tubules/drug effects , Kidney Tubules/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Postoperative Complications
4.
Handchir Mikrochir Plast Chir ; 42(6): 337-41, 2010 Dec.
Article in German | MEDLINE | ID: mdl-20405372

ABSTRACT

Today liver transplantation is the only curative option for the treatment of end-stage liver diseases. A major limitation of liver transplantation is the donor organ shortage. Therefore, tissue engineering based cell transplantation is currently under investigation with the aim to replace liver tissue and function. The principle of tissue engineering is the notion of an interaction between a cell and a three-dimensional matrix. The matrix serves as a scaffold and guides a three-dimensional cell assembly. In addition, the matrix provides for a regulation of cell proliferation and function by cell-matrix interactions. In cultures of hepatocytes a regulation of cell proliferation and specific function by using three-dimensional matrices and by modifying the surface with isolated molecules of the extracellular matrix has been demonstrated. Furthermore, a beneficial effect of a flow bioreactor system on cell viability and function was observed. In addition, a system for heterotopic hepatocyte transplantation on polymeric matrices was developed in an animal model. In this transplantation model a long-term proliferation and function of transplanted hepatocytes was shown. The major limitation of matrix-based transplantation systems is the high initial cell loss, most probably due to an insufficient vascularisation. Thus, the development of vascularised matrices and the creation of bile ducts remain major problems in the technologies of hepatic tissue engineering and have to be addressed to enable further advances towards clinical applications.


Subject(s)
Hepatocytes/transplantation , Liver Failure/surgery , Liver Transplantation/methods , Stem Cell Transplantation/methods , Tissue Engineering/methods , Animals , Bioreactors , Cell Division/physiology , Guided Tissue Regeneration/methods , Humans , Tissue Culture Techniques/methods , Tissue Scaffolds
5.
J Cell Mol Med ; 14(1-2): 267-74, 2010 Jan.
Article in English | MEDLINE | ID: mdl-18505475

ABSTRACT

The use of foetal liver cells (FLC) in the context of hepatic tissue engineering might permit efficient in vitro expansion and cryopreservation in a cell bank. A prerequisite for successful application of bioartificial liver tissue is sufficient initial vascularization. In this study, we evaluated the transplantation of fibrin gel-immobilized FLC in a vascularized arterio-veno-venous (AV)-loop model. FLC were isolated from embryonic/foetal (ED 16) rat livers and were enriched by using magnetic cell sorting (MACS). After cryopreservation, FLC were labelled by pkh-26. Cells were transplanted in a fibrin matrix into a subcutaneous chamber containing a microsurgically created AV-loop in the femoral region of the recipient rat. The chambers were explanted after 14 days. Subcutaneous implants without an AV-loop and cell-free implants served as controls. Fluorescence microscopy of the constructs was used to identify pkh-26(+)- donor cells. Characterization was performed by RT-PCR and immunhistology (IH) for CK-18 and CD31. Transplantation of FLC using the AV-loop permitted a neo-tissue formation in the fibrin matrix. A high-density vascularization was observed in the AV-loop constructs as shown by CD31 IH. Viable foetal donor cells were detected which expressed CK-18. FLC can be successfully used for heterotopic transplantation. Fibrin matrix permits rapid blood vessel ingrowth from the AV-loop and supports engraftment of FLC. It is therefore an appropriate environment for hepatocyte transplantation in combination with microsurgical vascularization strategies. Transplantation of fibrin gel-immobilized FLC may be a promising approach for the development of highly vascularized in vivo tissue-engineering-based liver support systems.


Subject(s)
Cell Culture Techniques , Fetus/cytology , Hepatocytes/transplantation , Animals , Cell Differentiation , Female , Fibrin/metabolism , Hepatocytes/cytology , Hepatocytes/physiology , Humans , Immunomagnetic Separation , Liver, Artificial , Pregnancy , Rats , Rats, Inbred Lew , Tissue Engineering/methods , Tissue Scaffolds/chemistry
6.
Zentralbl Chir ; 134(6): 502-6, 2009 Dec.
Article in German | MEDLINE | ID: mdl-20020380

ABSTRACT

Congenital diaphragmatic hernia (CDH) occurs sporadically with an incidence of 1:2,500 live births. Despite the progress in neonatal intensive care, CDH remains associated with a mortality of at least 30 % in isolated cases. The in essence surgically correctable defect of the diaphragm enables the prenatal herniation of abdominal organs into the thoracic cavity. The resulting abnormal development of the airways and pulmonary vessels causes neonatal respiratory insufficiency and persistent pulmonary hypertension. The condition can be diagnosed prenatally and the degree of pulmonary hypoplasia, which determines the postnatal course, can be measured to make an -individual prognosis. In severely affected patients, prenatal surgery may improve neonatal outcome by reversing pulmonary hypoplasia. This is currently implemented by percutaneous fetoscopic endoluminal tracheal occlusion (FETO) to trigger fetal lung growth. Although there are no maternal complications, preterm rupture of the membranes remains the major drawback of the procedure (20 % < 34 weeks). However, as compared to historical controls of a similar severity, survival as well as early neonatal morbidity are significantly improved by FETO. As a consequence, a multicentre randomised-controlled trial in fetuses with moderate hypoplasia on FETO compared to expectant management has been started ( www.totaltrial.eu). Primary outcome measure is survival without chronic lung disease (i. e., with-out bronchopulmonary dysplasia). A trial in severely affected -fetuses with survival as main outcome is currently under review by ethics committee. A standardised neonatal management enables optimal treatment and multicentre compatibility. It remains to be proven if fetoscopic surgery can maintain a solid position in the prenatal treatment of CDH to improve both mortality and morbidity of the affected children.


Subject(s)
Fetal Therapies/methods , Fetoscopy/methods , Hernia, Diaphragmatic/surgery , Hernias, Diaphragmatic, Congenital , Female , Fetal Membranes, Premature Rupture/etiology , Fetal Organ Maturity/physiology , Fetal Therapies/mortality , Hernia, Diaphragmatic/embryology , Hernia, Diaphragmatic/mortality , Humans , Infant, Newborn , Lung/abnormalities , Lung/embryology , Postoperative Complications/etiology , Postoperative Complications/mortality , Pregnancy , Randomized Controlled Trials as Topic , Survival Rate , Trachea/surgery
7.
Transplantation ; 86(9): 1267-74, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-19005409

ABSTRACT

BACKGROUND: Acute rejection increases the risk of late renal allograft loss with tubular atrophy, interstitial fibrosis, and microvascular rarefaction. Evidence supports a role for macrophages in promoting allograft injury, but the pathogenic mechanisms are unclear. Using a model of acute rejection, we sought evidence of macrophage-mediated endothelial cell cytotoxicity leading to loss of the renal microvasculature. METHODS: We used a transgenic conditional ablation strategy to deplete circulating monocytes and infiltrating renal macrophages after kidney transplantation. CD11b-DTR mice (FVB/nj strain) are transgenic for the human diphtheria toxin receptor gene under the control of the CD11b promoter. Administration of diphtheria toxin results in rapid ablation of circulating monocytes and resident/infiltrating renal macrophages. Transplants were performed between fully mismatched strains (Balb/c donor into control nontransgenic FVB/nj recipient; allograft group), between FVB/nj littermates (isograft group), and from Balb/c donors into CD11b-DTR mice (DT-treated group). Diphtheria toxin was administered at days 3 and 5, and the effect of monocyte/macrophage depletion on changes in renal microvasculature was determined at day 7. RESULTS: Conditional monocyte and macrophage ablation effectively depleted infiltrating macrophages in murine renal allografts at day 7. Macrophage ablation reduced histologic features of rejection (arteritis, tubulitis) and the accompanying rarefaction of peritubular capillaries at 7 days. The identification of macrophages immunopositive for inducible nitric oxide synthase implicated nitric oxide generation as a possible mechanism of endothelial cell cytotoxicity. CONCLUSION: These data indicate a significant role for macrophages in causing acute rejection-related tissue injury that is, at least in part, targeted to the microcirculation.


Subject(s)
Kidney Transplantation/pathology , Kidney/blood supply , Macrophages/pathology , Microvessels/pathology , Monocytes/pathology , Animals , Apoptosis/drug effects , CD11b Antigen/genetics , CD11b Antigen/metabolism , Dendritic Cells/drug effects , Diphtheria Toxin/pharmacology , Forkhead Transcription Factors/metabolism , Graft Rejection/pathology , Heparin-binding EGF-like Growth Factor , Humans , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Interferon-gamma/metabolism , Interleukin-12/metabolism , Macrophages/drug effects , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Mice, Transgenic , Models, Animal , Monocytes/drug effects , Monocytes/metabolism , Nitric Oxide Synthase Type II/metabolism , Poisons/pharmacology , Transplantation, Homologous
9.
Kidney Int ; 72(3): 234-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17653230

ABSTRACT

Macrophages are inflammatory cells with important roles in the propagation of renal injury. More recently they have also been shown to be important in the resolution of inflammation. Wang et al. show that macrophages can be modulated ex vivo by cytokine stimulation, localize to renal tissue, and slow progression of experimental glomerular inflammation. Thus strategies targeting macrophage function have considerable therapeutic potential.


Subject(s)
Glomerulonephritis/prevention & control , Macrophages/drug effects , Macrophages/physiology , Animals , Cytokines/physiology , Glomerulonephritis/chemically induced , Glomerulonephritis/physiopathology , Inflammation , Kidney/cytology , Kidney/pathology , Macrophages/transplantation , Mice
10.
J Cell Mol Med ; 10(3): 577-87, 2006.
Article in English | MEDLINE | ID: mdl-16989722

ABSTRACT

For the development of innovative cell-based liver directed therapies, e.g. liver tissue engineering, the use of stem cells might be very attractive to overcome the limitation of donor liver tissue. Liver specific differentiation of embryonic, fetal or adult stem cells is currently under investigation. Different types of fetal liver (stem) cells during development were identified, and their advantageous growth potential and bipotential differentiation capacity were shown. However, ethical and legal issues have to be addressed before using fetal cells. Use of adult stem cells is clinically established, e.g. transplantation of hematopoietic stem cells. Other bone marrow derived liver stem cells might be mesenchymal stem cells (MSC). However, the transdifferentiation potential is still in question due to the observation of cellular fusion in several in vivo experiments. In vitro experiments revealed a crucial role of the environment (e.g. growth factors and extracellular matrix) for specific differentiation of stem cells. Co-cultured liver cells also seemed to be important for hepatic gene expression of MSC. For successful liver cell transplantation, a novel approach of tissue engineering by orthotopic transplantation of gel-immobilized cells could be promising, providing optimal environment for the injected cells. Moreover, an orthotopic tissue engineering approach using bipotential stem cells could lead to a repopulation of the recipients liver with healthy liver and biliary cells, thus providing both hepatic functions and biliary excretion. Future studies have to investigate, which stem cell and environmental conditions would be most suitable for the use of stem cells for liver regeneration or tissue engineering approaches.


Subject(s)
Cell Culture Techniques/methods , Liver Diseases/therapy , Liver Regeneration , Liver/cytology , Liver/embryology , Stem Cells/cytology , Tissue Engineering/instrumentation , Tissue Engineering/methods , Animals , Bone Marrow Cells/cytology , Hepatocytes/cytology , Humans , Liver/metabolism
11.
Eur J Pediatr Surg ; 16(6): 407-10, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17211788

ABSTRACT

INTRODUCTION: Dilatation and impaired function of the gut is a condition often seen in newborns with bowel obstruction caused by intestinal atresia. In a previous experimental study in chicken embryos, we established a model to study ultrastructural changes during the development of the enteric nervous system after small bowel ligation. The aim of this study is to investigate the changes of the enteric nervous system (ENS) after gut ligation. METHODS: 56 chicken embryos were investigated. In the operation group fertilized eggs and the allantoic membrane were opened and the small bowel was ligated on embryonal day (ED) 11. The controls were sham-operated. The gut was prepared and harvested for analysis on ED 11, 12, 13, 14, 15, 16, 17 and 18. Silver staining or staining of the specimens for acetylcholinesterase (AchE) was performed. RESULTS: A marked dilatation of the bowel was observed three days after operation (ED 14). The submucosal (PSM) and myenteric plexus (PM) appeared normal at this time, however silver staining showed rarification of the neuronal axonal network between the myenteric and submucosal plexus. Later, on ED 16 an additional rarification of the submucosal plexus was also seen in the operation group using AchE staining, compared to the controls. DISCUSSION: The data suggest that distension of the gut hinders normal development of the ENS in the gut ligation model of chicken embryos. The changes were observed sequentially, starting with rarification of the axonal network between the PM and PSM. Future studies will be required to show whether the changes of the ENS are reversible.


Subject(s)
Intestines/embryology , Intestines/innervation , Myenteric Plexus/embryology , Submucous Plexus/embryology , Submucous Plexus/physiopathology , Animals , Chick Embryo , Dilatation , Intestinal Atresia , Intestines/growth & development , Ligation , Models, Animal , Myenteric Plexus/growth & development , Myenteric Plexus/physiopathology , Submucous Plexus/growth & development
12.
Transplant Proc ; 37(1): 276-9, 2005.
Article in English | MEDLINE | ID: mdl-15808618

ABSTRACT

The origin of liver cells from distinct bone marrow stem cells, eg, hematopoietic stem cells or multipotent adult progenitor cells has been recently described using in vitro studies. Cell culture experiments revealed the key role of growth factors and the organ-specific environment for the induction of liver-specific genes. We investigated the in vitro potential of rat mesenchymal stem cells to differentiate into hepatocytic cells in cocultures with isolated rat liver cells. Rat mesenchymal stem cells (MSCs) propagated in culture, and transduced with green fluorescent protein (GFP) were cloned. Cells from selected clones were either cultured under liver-stimulating conditions, using serum free medium supplemented with HGF, EGF, SCF, and FGF-4 alone on fibronectin-coated surfaces, or cocultured with freshly isolated rat liver cells. Cocultured cells were harvested after two weeks and sorted into GFP-positive (GFP+) and GFP-negative (GFP-) cells. RT-PCR for liver specific markers CK-18 and albumin were performed on the different cell populations. After 2 weeks, the specified culture conditions led to the expression of albumin and CK-18 RNA in GFP-positive sorted MSCs from the cocultures, whereas MSCs cultured without liver cells did not express the studied genes. The results indicate, that when cocultured with liver cells MSCs from the bone marrow have the potential to differentiate toward hepatocytic cells in vitro. We conclude that MSC may possess an enhanced capacity to differentiate into functional liver cells. Additionally, environmental factors seem to be crucial for specific and directed differentiation.


Subject(s)
Hepatocytes/physiology , Liver/cytology , Mesoderm/cytology , Stem Cells/cytology , Animals , Cell Differentiation/drug effects , Cells, Cultured , Coculture Techniques , Epidermal Growth Factor/pharmacology , Fibroblast Growth Factors/pharmacology , Genes, Reporter , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Hepatocyte Growth Factor/pharmacology , Hepatocytes/cytology , Liver/drug effects , Liver/physiology , Rats , Stem Cell Factor/pharmacology , Stem Cells/physiology
13.
Semin Pediatr Surg ; 12(4): 275-9, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14655167

ABSTRACT

Until today, the puzzling spectrum of midgut "malrotations" is commonly explained by an "impaired" process of rotation of the midgut. However, a closer look at the literature reveals that the description of this "process of rotation" is rather schematic and is aimed more at explaining pathological findings, while detailed proper embryological investigations are still rare. Despite recent trials, good animals models that would allow the comparison of normal and abnormal midgut development are still missing. In the first part of this article, the "normal process of rotation," as it is described in the literature, is presented and critically analyzed. In general, it is a shortcoming that reliable illustrations of these crucial embryological processes are missing in most of these papers. Therefore, in the second part of this review scanning electron microscopy pictures of the developing midgut are presented in a series of rat embryos. In these pictures clear signs of a process of rotation are missing.


Subject(s)
Intestines/abnormalities , Intestines/embryology , Animals , Digestive System Abnormalities/embryology , Humans , Infant, Newborn , Rats , Rotation
14.
Nephron Exp Nephrol ; 94(4): e113-8, 2003.
Article in English | MEDLINE | ID: mdl-12972709

ABSTRACT

Macrophages are key players in the development of the majority of renal diseases and are therefore ideal cellular vectors for site specifically targeting gene therapy to inflamed glomeruli. Macrophages can be genetically modified using viral vectors ex vivo then re-introduced into the body where they can home to the diseased site. This review summarises current experience in efficiently targeting modified macrophages to the inflamed glomerulus focussing on the factors controlling macrophage localisation, macrophage gene transfer methods, in vivo gene delivery and results of recent investigations using modified macrophage gene therapy for glomerular disease.


Subject(s)
Cell Movement/genetics , Kidney Glomerulus/pathology , Macrophage Activation/genetics , Macrophages/physiology , Macrophages/transplantation , Adenoviridae/genetics , Animals , Cell Movement/physiology , Gene Transfer Techniques , Genetic Engineering/methods , Glomerulonephritis/pathology , Glomerulonephritis/therapy , Humans , Immunotherapy, Adoptive/methods , Macrophages/virology
15.
J Pediatr Surg ; 37(5): 730-4, 2002 May.
Article in English | MEDLINE | ID: mdl-11987089

ABSTRACT

BACKGROUND/PURPOSE: Pulmonary hypertension and pulmonary hypoplasia account for the high mortality rate associated with congenital diaphragmatic hernia (CDH). In animal models of CDH, postnatal nitric oxide (NO) inhalation resulted in significantly better survival rates and antenatal glucocorticoid administration in improved lung compliance. The objective of this study was to evaluate the combined effect of prenatal glucocorticoid administration and postnatal NO inhalation on the survival rate of newborn rats with nitrofen-induced CDH. METHODS: Right-sided CDH was induced by maternal administration of a single oral dose (100 mg, intraperitoneally) of nitrofen on day 11.5 of pregnancy. Dexamethasone (DEX, 0.25 mg/kg) was given in groups III and IV by maternal intraperitoneal injection on day 18.5 and 19.5 of pregnancy. Control animals (groups I and II) received vehicle alone. After spontaneous delivery, the newborn animals were exposed to either NO (80 ppm; groups II and IV) or room air (groups I and III). Vitality (Rat-Score), sO(2) and survival were monitored continuously for 12 hours until animals were killed. Hernia size was estimated as percentage of total thoracic content. RESULTS: Right-sided CDH was observed in 392 of 491 newborn rats (81%). Animals with large hernias (>50%) died within 4 hours after birth, irrespective of treatment. Hernias with less than 50% of the thoracic volume were considered clinically relevant hernias. In this category, 12.5% of animals without treatment (group I) survived compared with 63.6% after NO treatment alone (group II; P <.01). Survival rate after DEX treatment alone (group III) was 69.4% (group III v I; P <.01). In group IV (DEX and NO) 95.2% of the animals survived (group IV v I; P <.001). In contrast to DEX alone, NO administration resulted in significantly better sO(2)(group II and IV) compared with group I (P <.05). CONCLUSION: Combination of prenatal maternal glucocorticoids and postnatal NO inhalation significantly improved survival rate of newborn rats with nitrofen-induced CDH.


Subject(s)
Dexamethasone/administration & dosage , Hernia, Diaphragmatic/drug therapy , Hernias, Diaphragmatic, Congenital , Nitric Oxide/administration & dosage , Administration, Inhalation , Animals , Female , Hernia, Diaphragmatic/chemically induced , Hernia, Diaphragmatic/physiopathology , Injections, Intraperitoneal , Lung Compliance/drug effects , Male , Phenyl Ethers , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Sprague-Dawley , Survival Rate
16.
Dig Surg ; 18(3): 196-203, 2001.
Article in English | MEDLINE | ID: mdl-11464009

ABSTRACT

BACKGROUND: An optimal method for hepatocyte transplantation is not yet determined. With the principles of tissue engineering in vitro conditioning of hepatocytes on biodegradable polymer in a flow bioreactor before implantation forming spheroids may achieve increased cell mass and function to replace lost organ function in vivo. METHODS: Biodegradable poly-L-lactic (PLLA) polymer discs were seeded with rat hepatocytes in a concentration of 10 x 10(6) cells per ml and exposed to a medium flow of 24 ml/min for 1, 2, 4 and 6 days. The number and diameter of spheroidal aggregates was measured by phase-contrast microscopy. H&E histology was performed. Albumin production as hepatocyte specific function was determined by ELISA. RESULTS: Spheroids of viable hepatocytes of 50-200 microm in diameter were formed. Both the number and diameter of the spheroids increased during the first 2 days and then remained constant until day 6. Albumin production was maintained throughout the culture period. CONCLUSION: Short (2- 3 days) pre-transplant conditioning of hepatocytes in a flow bioreactor on biodegradable PLLA resulted in formation of spheroids with a liver-like morphology and preserved specific metabolic function. Tissue engineered hepatocyte spheroids on polymer may represent a functionally active and easy transplantable neotissue and may serve as an in vivo substitute for lost liver function.


Subject(s)
Biocompatible Materials , Biomedical Engineering/methods , Hepatocytes/transplantation , Polymers , Spheroids, Cellular/transplantation , Albumins/metabolism , Animals , Biomedical Engineering/instrumentation , Bioreactors , Cell Transplantation/methods , Hepatocytes/metabolism , In Vitro Techniques , Lactic Acid/metabolism , Liver Transplantation , Pulsatile Flow , Rats , Rats, Inbred Lew , Spheroids, Cellular/metabolism , Time Factors
17.
Dig Surg ; 18(3): 204-10, 2001.
Article in English | MEDLINE | ID: mdl-11464010

ABSTRACT

BACKGROUND/AIMS: Widespread clinical application of islet transplantation remains restricted, because of insufficient methods to prevent rejection and autoimmune destruction of islet grafts. In this study we demonstrate long-term function of islets of Langerhans within a capsule of porcine chondrocytes which may serve as an immunoisolation barrier utilizing the immunoprivileged properties of the chondrocyte matrix. METHODS: Islets of Langerhans were isolated from Lewis rats, seeded on biodegradable polyglycolic acid polymer, and encapsulated with a monolayer of porcine chondrocytes. The encapsulated constructs and controls were kept in culture for 5 weeks. One group was exposed to a glucose challenge every 5th day. The insulin concentration of the culture medium was measured. Histological and insulin-immunohistochemical studies were performed. RESULTS: Hematoxylin and eosin histology demonstrated viability of the islets of Langerhans. The intact morphology was demonstrated by Heidenhain staining. Toluidine blue showed viability of surrounding chondrocyte layers. Immunohistochemistry was positive for insulin within the beta cells of the islets. Both encapsulated constructs and nonencapsulated controls showed increasing insulin levels after glucose challenge. CONCLUSIONS: We can tissue engineer a chondrocyte encapsulation membrane which permits diffusion of glucose and insulin. Islets of Langerhans survive within the chondrocyte capsule, and the glucose/insulin feedback mechanism remains intact.


Subject(s)
Chondrocytes/immunology , Graft Rejection/prevention & control , Islets of Langerhans Transplantation/immunology , Islets of Langerhans Transplantation/methods , Islets of Langerhans/metabolism , Animals , Biocompatible Materials , Cells, Cultured , Glucose , Graft Rejection/immunology , Immunohistochemistry , In Vitro Techniques , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/immunology , Polyglycolic Acid , Rats , Rats, Inbred Lew , Swine , Transplantation, Autologous/methods
18.
Transplantation ; 71(9): 1226-31, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11397954

ABSTRACT

BACKGROUND: Hepatocyte transplantation using polymeric matrices is under investigation as an alternative therapy for metabolic liver diseases. Long-term engraftment of hepatocytes in polymers has been demonstrated. However, the metabolic activity of hepatocytes in such devices has never been assessed in direct comparison with liver grafts. METHODS: Hepatocyte and partial liver transplantation were evaluated in the scurvy-prone osteogenic disorder Shionogi rat model. Biodegradable poly glycolic acid matrices seeded with hepatocytes equivalent to 20% of the recipient's liver mass, or 20% liver grafts were heterotopically transplanted into ascorbic acid- (AsA) deficient recipients. Recipients of cell-free matrices or AsA-deficient liver grafts served as controls. Recipients were set on AsA-free diet after transplantation. Plasma AsA levels, AsA concentrations in liver and adrenal gland tissue, and body weight ratios were assessed and H&E histology was performed. RESULTS: Recipients from the control groups showed symptoms of scurvy at 1 month after cessation of AsA supply. Hepatocyte transplantation and auxiliary liver transplantation prevented symptoms of scurvy and increased plasma and tissue AsA levels and body weight ratios. AsA levels in recipients of 20% liver grafts were comparable to normal control animals. CONCLUSIONS: Hepatocytes transplanted in polymeric matrices are able to compensate for liver-based metabolic deficiencies. Hepatocyte transplantation improves plasma AsA levels in AsA-deficient recipients. However, auxiliary liver grafts are superior to hepatocyte grafts in improving metabolic parameters. Further research work is needed to increase the efficiency of liver cell transplantation with regard to a clinical application.


Subject(s)
Biodegradation, Environmental , Hepatocytes/transplantation , Animals , Ascorbic Acid Deficiency/metabolism , Biocompatible Materials/administration & dosage , Liver Transplantation , Male , Models, Animal , Rats , Rats, Mutant Strains , Rats, Wistar , Transplantation, Heterotopic
19.
Cells Tissues Organs ; 169(1): 34-41, 2001.
Article in English | MEDLINE | ID: mdl-11340259

ABSTRACT

We hypothesize that in vitro conditioning of hepatocytes within biodegradable poly-L-lactic acid (PLLA) polymer matrices prior to implantation may increase hepatocyte survival and function after transplantation. The purpose of this study was to optimize the culture conditions of hepatocytes in a pulsatile flow bioreactor. PLLA discs were seeded with rat hepatocytes in a concentration of 2.5, 5, 10, 20 and 40 x 10(6) cells/ml. Seeded discs were exposed to recirculated perpendicular flow of 0, 7, 15, 24, 32, 52 ml/min of supplemented Williams' Medium E and harvested after 6 days in flow culture. Only under flow conditions the hepatocytes formed spheroidal aggregates (SphA) of 50-260 microm in diameter with a liver-like morphology and active metabolic function. The number of SphA was examined by phase contrast microscopy and the reductive enzyme function of the hepatocytes was tested using MTT. Hematoxylin and eosin histology showed vital hepatocytes within the SphA less than 200 microm in diameter but central necrosis in the SphA exceeding this size. Immunohistochemical staining confirmed albumin production of hepatocytes within the SphA. The optimal cell seeding concentration was 10 x 10(6) cells/ml with a flow speed of 24 ml/min. SphA of hepatocytes cultured with this flow bioreactor method may prove useful as a functional unit for tissue engineering of an in vivo liver substitute.


Subject(s)
Biomedical Engineering/methods , Bioreactors , Cell Transplantation , Hepatocytes/cytology , Spheroids, Cellular/cytology , Albumins/metabolism , Animals , Biodegradation, Environmental , Cell Count , Cells, Cultured , Hepatocytes/metabolism , Hepatocytes/transplantation , Lactic Acid , Male , Polymers , Rats , Rats, Inbred Lew , Spheroids, Cellular/metabolism , Spheroids, Cellular/transplantation
20.
Curr Opin Nephrol Hypertens ; 10(3): 341-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11342795

ABSTRACT

This review describes recent advances in macrophage biology in the context of renal inflammation. It highlights the importance of the activated macrophage for the progression and resolution of renal disease, and discusses recent and potential future approaches to modify macrophage function selectively within the kidney to activate them specifically to promote the healing of kidney disease.


Subject(s)
Kidney Diseases/immunology , Macrophages/immunology , Humans , Inflammation/etiology , Inflammation/immunology , Kidney Diseases/etiology , Macrophage Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...